In our analysis, PSA values < 4 vs. ≥ 4 ng/mL, prostate cancer risk stratification at RP (Figure 3A–3D), or histopathology findings at sLND (Figure 5A–5D) did not significantly influence CR-free survival and CSS rates. This evidence concerns the gene KLK3 and Familial prostate cancer.